Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Xingchao Zhu"'
Autor:
Jiayu Wang, Mengxin Zhu, Jinghan Zhu, Juntao Li, Xingchao Zhu, Kun Wang, Kanger Shen, Kexi Yang, Xiangyu Ni, Xin Liu, Guangbo Zhang, Qinhua Xi, Tongguo Shi, Weichang Chen
Publikováno v:
Cell Death Discovery, Vol 9, Iss 1, Pp 1-10 (2023)
Abstract Aerobic glycolysis has been shown to play a key role in tumor cell proliferation and metastasis. However, how it is directly regulated is largely unknown. Here, we found that HES1 expression was significantly higher in CRC tissues than that
Externí odkaz:
https://doaj.org/article/474eeaf016cf4acbae3fa3766fda4b73
Autor:
Jinming Zhang, Junmin Zhang, Ruiqi Yuan, Wenxin Han, Yuan Chang, Lingyang Kong, Chunling Wei, Qiaohua Zheng, Xingchao Zhu, Zhiqiang Liu, Wei Ren, Jing Han
Publikováno v:
iScience, Vol 27, Iss 2, Pp 108919- (2024)
Summary: Recent studies have demonstrated the pivotal involvement of endocannabinoids in regulating learning and memory, but the conclusions obtained from different paradigms or contexts are somewhat controversial, and the underlying mechanisms remai
Externí odkaz:
https://doaj.org/article/84b560a170e140118e2f894ddbb30dcd
Autor:
Xingchao Zhu, Zhiyong Zhu
Publikováno v:
Fractals.
Autor:
Xingchao Zhu, Zhiyong Zhu
Publikováno v:
International Journal of Modern Physics C. 34
The spectrum of normalized Laplacian matrix of a network has attracted more and more attention because it is related to the structural properties and dynamical aspects of the network, specially in random walks. In this paper, we study the spectra and
Publikováno v:
Zhonghua zhong liu za zhi [Chinese journal of oncology]. 37(6)
To study the molecular mechanism of cisplatin to enhance the ability of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in reversing multidrug resistance in vincristine-resistant human gastric cancer SGC7901/VCR cells.MTT assay was us
Publikováno v:
Medical Oncology. 32
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses multidrug resistance (MDR) and induces apoptosis in MDR gastric carcinoma cells. In our previous study, cisplatin proved to be a sensitizing agent for TRAIL. To study the synerg